Abstract TMC1 encodes a protein required for the normal function of mechanically activated channels that enable sensory transduction in auditory and vestibular hair cells. TMC1 protein is localized at the tips of the hair cell stereocilia, the site of conventional mechanotransduction. In many populations, loss-of-function recessive mutations of TMC1 are associated with profound deafness across all frequencies tested. In six families reported here, variable moderate-to-severe or moderate-to-profound hearing loss co-segregated with STR (short tandem repeats) markers at the TMC1 locus DFNB7/ 11. Massively parallel and Sanger sequencing of genomic DNA revealed each family co-segregating hearing loss with a homozygous TMC1 mutation: two reported mutations (p.R34X and p.R389Q) and three novel mutations (p.S596R, p.N199I, and c.1404 + 1G > T). TMC1 cDNA sequence from affected subjects homozygous for the donor splice site transversion c.1404 + 1G > T revealed skipping of exon 16, deleting 60 amino acids from the TMC1 protein. Since the mutations in our study cause less than profound hearing loss, we speculate that there is hypo-functional TMC1 mechanotransduction channel activity and that other even less damaging variants of TMC1 may be associated with more common mild-to-severe sensorineural hearing loss.
Introduction
In humans, recessive mutations of TMC1 cause congenital non-syndromic severe to profound deafness DFNB7/11, while dominant alleles of TMC1 are associated with progressive loss of hearing DFNA36 [1] [2] [3] . In mouse, mutations of Tmc1 cause recessive profound hearing loss (dn, deafness) and dominantly inherited progressive hearing loss (Bth, Beethoven) [4, 5] . In the inner ear, the morphology of the neurosensory hair cells in the dn mouse appears initially to be normal until 2 weeks of age after which they degenerate [4, 5] .
TMC1 belongs to the transmembrane channel-like (TMC) gene family of eight members that have a conserved 120 residue TMC domain of unknown function [2] . The longest Ayesha Imtiaz and Azra Maqsood contributed equally to this work.
isoform of human TMC1, NM_138691.2, encodes a 760 amino acid residue protein that contains at least six experimentally demonstrated transmembrane domains with intracellular N and C termini [6] . TMC1 contributes to channel properties and is a candidate for a subunit of the pore-forming complex of the elusive mechanotransduction channel at the tips of the shorter-row stereocilia, or a linker between protocadherin-15 and the pore-forming subunits [7] [8] [9] [10] [11] .
TMC1 mutations are one of the five major causes of profound recessive deafness worldwide [1, 2, [12] [13] [14] [15] , accounting for 6 % of deafness in an Eastern Turkish population [16] , and 3 to 5 % in Tunisian, European, Indian, and Pakistani populations [1, 17, 18] . In this study, we describe six large consanguineous families, five of which segregate mutations of TMC1 with variable moderate-to-profound hearing loss. In the Pakistani population, TMC1 variants contribute approximately 7 % to the etiology of moderate-to-profound hearing loss, which is even higher than its reported contribution to profound deafness [1] .
Methods

Clinical evaluation
Institutional review board approvals were obtained for this study from the School of Biological Sciences, University of the Punjab, Lahore, Pakistan, and from the Combined Neuroscience Institutional Review Board (protocol OH-93-N-016) National Institutes of Health, USA. Families were enrolled by visiting schools for individuals with varying disabilities located in different cities of the Punjab Province of Pakistan. Written informed consents were obtained from the participating individuals. Medical history interviews were conducted for all affected individuals. Pure tone audiometry was performed (250, 500, 1000, 2000, 4000, and 8000 Hz) in ambient noise conditions since sound-proof rooms were not available, which may have overestimated the degree of hearing loss (HL). Degree of the hearing loss was classified as mild (20-40 dB HL), moderate (41-70 dB HL), severe (71-95 dB HL), and profound (>95 dB HL) [19] . For sloping audiograms, the range of hearing loss was defined from lowest threshold to the highest threshold across all six frequencies tested. Octave frequencies from 500 to 4000 Hz were used to calculate pure tune averages (PTA).
Massively parallel and Sanger sequencing
Blood samples were collected from available and consenting individuals of the families, and the DNA was extracted using a standard nonorganic protocol [20] . Samples from 84 families were screened for variants of GJB2 by Sanger sequencing [21] . Possible involvement of TMC1 with hearing loss was screened by either homozygosity mapping using genetic markers D9S1837 and D9S1876 or targeted resequencing of the known deafness genes using a custom-designed SureSelect capture library [22] , followed by massively parallel sequencing on an ABI5500 SOLiD instrument. Maximum two-point LOD scores were calculated at θ = 0.00 using easyLINKAGE plus v5.02 software (http://nephrologie.uniklinikum-leipzig.de/ nephrologie.site, postext,easylinkage,a_id,372.html), assuming equal allele frequencies with hearing loss coded as a completely penetrant trait. Sanger sequencing of the 24 exons of TMC1 (NM_138691.2) and the surrounding intronic sequences was performed for families segregating hearing loss linked to DFNB7/11.
To check the effect of a novel splice variant, total RNA was extracted from buffy coat obtained from whole blood of two affected (IV:3 and IV:5), one carrier (III:3), and unaffected individuals using a silica membrane spin column (GeneJET Whole Blood RNA Purification Mini Kit, Fermentas, MD, USA) with subsequent DNase treatment. A complementary DNA (cDNA) library was synthesized using a Revert Aid™ Premium first-strand cDNA synthesis kit(Fermentas). TMC1-specific primers were used for the preparation of cDNA (GCTATCACAGAAGAAAAAGCAGCCCAAGTAG, and ACCATTGTTTCCCAGCAAGGTCCTC). An internal set of primers (TCCTGAGGTTTCTGGCTAACTTCTTCGTG and TCAGAGAATGATGCATTGTAGGCCTTG) amplified a TMC1 fragment which included exons 15-17. Variants identified in TMC1 were checked to see if they were present in the public databases including dbSNP (http://www. ncbi.nlm.nih.gov/projects/SNP/), clinical variation database (http://clinvitae.invitae.com/), HGMD (http://www.hgmd.cf.ac. uk/ac/index.php), and ExAC (http://exac.broadinstitute.org/). The pathogenicity of the novel variants was predicted by Mutation Taster (http://www.mutationtaster.org/), Polyphen2 (http://genetics.bwh.harvard.edu/pph2/), and SIFT (http://sift. bii.astar.edu.sg/). Multiple sequence alignments were performed with Clustal Omega (http://www.ebi.ac.uk/Tools/ msa/clustalo/). Protein sequences were obtained from UniProt (http://www.uniprot.org/). The frequencies of the novel variants were evaluated either by Tetra-ARMS PCR [23] or by Sanger sequencing using genomic DNA from 150 ethnicity-matched normal-hearing individuals.
Results
Clinical data and molecular genetic analyses
Affected individuals in the families included in this study had congenital but variable degrees of hearing loss, which ranged from moderate-to-severe, moderate-to-profound, severe, or severe-to-profound in each family. All affected individuals had down sloping audiograms showing lesser hearing for higher frequencies. Longitudinal audiometric data was not available for any affected individual. Hearing loss in families HLAM02, PHLAI-1, and HLAI-27 may be progressive since the youngest affected individuals have better hearing thresholds as compared to the other affected subjects in their families ( Table 2 , Fig. 1b) .
Hearing loss segregating in six families was consistent with linkage to STR genetic markers for DFNB7/11 (LOD scores 2.86 to 3.48, Table 1 ). Three novel and two known variants of TMC1 were identified in five of these families. The two novel missense mutations (c.1788C > A (p.S596R) and c.596A > T (p.N199I) segregated in families HLAI-14 and HLAI-27, respectively (Fig. 1a) , while a splice site variant (c.1404 + 1G > T) co-segregated with hearing loss in family HLAI-04. All three novel variants were absent from normal ethnically matched controls (Table 1) .
One affected individual (IV:5) in family HLAI-04 has a strikingly different moderate-to-severe hearing loss (PTA: 65 dB HL) as compared to the severe-to-profound hearing loss in the other two affected (IV:1 and IV:3) individuals (PTA: 93 and 100 dB HL) in his family ( Table 2 Human Splicing Finder (http://www.umd.be/HSF/) predicted that the last exonic nucleotide of exon 16 would be used with the intronic transversion (g > t) and serve as an alternate donor Bgt^consensus splice site. This predicted donor site would delete a single nucleotide and introduce a frameshift in the open-reading frame of TMC1. However, analysis of cDNA derived from two patients' (IV:3 and IV:5) blood samples revealed that the variant causes the skipping of exon 16, which deleted 60 codons, thus removing 60 residues (methionine 409 to lysine 468) from the predicted third extracellular domain (Fig. 2a, b) [6] .
Novel missense variants p.N199I and p.S596R were associated with moderate-to-severe hearing loss in younger affected individuals (PTA 61, 70, and 75 dB HL) in families HLAI-27 (IV:3) and HLAI-14 (IV:3 and IV:4). Thresholds at higher frequencies were elevated in the older affected individuals (IV:1 in both pedigrees) who had moderate-to-profound hearing loss (PTA 80 and 87 dB HL) ( Table 2, Fig. 1b) . Additionally, homozygosity for either of the two known transition variants c.100C > T (p.R34X) [1] and c.1166G > A (p.R389Q) [26] was identified co-segregating with the hearing loss in families HLAM02 and PHLAI-01, respectively (Fig. 1a) . Severe or severe-to-profound hearing loss was present in the older affected individuals of HLAM02 (V:3 and V:4) and PHLAI-01 (IV:3) (PTA 85, 91, and 86 dB HL). However, the loss of hearing was either moderate-to-severe or moderateto-profound in the youngest affected individual IV:5 of each family (PTA 76 and 79 dB HL) ( Table 2, Fig. 1b) .
No pathogenic variant was identified for family HLAI-17 ( Fig. 1a) . A few possibilities might explain the lack of a variant in the 24 exons of TMC1. A disease causing mutation may exist in a cis-acting regulatory element of TMC1, or the mutation causing deafness in family HLAI-17 is located elsewhere among the 22 annotated genes within the 4.5-Mb linkage interval. Similarly, another family segregating deafness linked to markers for TMC1 failed to identify a mutant allele of TMC1 [26] , suggesting that this chromosomal interval may harbor a second deafness gene. There is precedence for mutations of neighboring genes, each causing deafness [28] [29] [30] [31] [32] [33] .
Protein structure predictions
The newly identified missense variants p.N199I and p.S596R affect residues that are located in the predicted first transmembrane helix and third cytoplasmic loop of TMC1, respectively. These residues are highly conserved in TMC1 proteins of various vertebrate species (Fig. 2c, d ). The p.N199I mutation is in the middle of a highly conserved region and substitutes a polar amino acid (N) for a hydrophobic residue (I). An asparagine residue (N) often terminates an alpha helical structure and can be localized just outside a membrane-spanning region where their polar side groups help anchor a hydrophobic helix in the membrane. Substitution of a hydrophobic isoleucine residue may disrupt the helical structure and perhaps the function of the first transmembrane domain (TM1). If, for example, p.N199 is required to anchor TM1 rigidly in the membrane, substitution for a more Bslippery^hydrophobic residue (such as the substitution 199I) may introduce compliance to the structure and thereby decrease channel sensitivity, altering the relationship between mechanical force and channel open probability. Since the mutation causes only moderate-toprofound hearing loss, there may be residual, but hypo-functional, mechanotransduction channel activity. Alternatively, since the p.G197R mutation [25] is just two amino acids away from the p.N199I site, it suggests that this region plays a significant role for TMC1 function. Both mutations occur at the junction between the N-terminal domain and the first transmembrane domain. The N-terminal region of TMC1 has been shown to interact with the tip-link molecule protocadherin-15 (10), encoded by PCDH15 [34] . Tip-links convey tension which gates mechanotransduction channels. Transmission of mechanical force from the tip-link via the TMC1 N-terminus to the rest of the TMC1 protein may require an intact junctional region between the N-terminus and the first transmembrane domain. Thus, if mutations in this region reduce force transmission, they may result in reduced sensitivity and hypo-functional mechanotransduction, which could account for the moderate-to-severe hearing loss in the patients who carry the G197R or the N199I mutations.
The p.R389Q and p.S596R mutations likely occur in the extracellular and the intracellular loops, respectively [6] . The physiological consequences of these mutations are difficult to predict, yet since the patients with these mutations retain some residual auditory function, it suggests that the cellular consequences may be less severe than those associated with loss-offunction mutations. For example, mutations that reduce the mechanotransduction current may result in reduced auditory function without a profound loss-of-function. Alternatively, the mutations may alter the affinity of TMC1 for unidentified binding partners and lead to a hypo-functional mechanosensory complex. Structural data for TMC1 may help distinguish among the various possibilities.
Discussion
Severe-to-profound hearing loss is the predominant phenotype associated with recessively inherited mutations in TMC1. Our data suggests that this association of profound deafness with mutations of TMC1 could be an ascertainment bias because individuals with moderate-to-severe hearing loss often are not enrolled in schools for deaf. To date, only four mutations of TMC1 have been reported to be associated with less severe hearing loss in three different families and include compound heterozygosity for a missense and stop gain variants and two predicted hypofunctional splice variants [31, 33, 34] . A compound heterozygosity for two TMC1 variants (p.G197R and p.Q391X) in two Chinese siblings resulted in a severe hearing loss (PTA : 88 dB HL and 97 dB HL) [25] . A homozygous splice site variant, c.776 + 1G > A was reported in three affected individuals with variable severe-to-profound deafness in an Iranian family [24] . Similarly, another homozygous splice variant (c.1763 + 3A > G) was reported to cause progressive, post-lingual, moderate-toprofound hearing loss in a Dutch family with three affected individuals. One of the affected individuals in this family had a less severe hearing loss with an overall PTA of 72.5 dB HL [27] .
The TMC1 splice site variant (c.1944 + 1G > T) results in an in-frame deletion of 60 amino acid residues (M409 to K468) as inferred from examination of RNA from patients' lymphocytes. However, the exact aberrant splicing event in the patient's cochlea is unknown. The region from M409 to K468 is important for TMC1 function since two reported dominant missense alleles located in the same region cause progressive hearing loss [35, 36] by a dominant negative or gain-offunction mechanisms [7] . However, haplo-insufficiency cannot explain the mechanism of action of the two dominant missense alleles since carriers of the reported null alleles of TMC1 have normal hearing [7] .
The p.R34X mutation present in family HLAM02 is a frequently reported allele, accounting for 30 % of all TMC1 mutations [37] . The individuals with the variant p.R34X found among Tunisians, Algerians, Iraqis, Iranians, and Pakistanis have the same haplotype, and therefore, this variant The amino acid residue p.S596 is not conserved in amphibians and fish is likely to be an ancient founder mutation. The age of p.R34X was estimated to be between 1075 and 1900 years old [37] . The variant codon, p.R34X, is located in exon 7, which is also part of an untranslated region of an annotated alternative splice isoform of TMC1 (uc004ajc.1, uc010mpa.1). The expression of short TMC1 isoforms might explain the moderateto-profound hearing loss associated with the p.R34X mutation in family HLAM02. However, the reported association of the p.R34X variant only with profound deafness does not support this possibility. Similarly, in a previous study, p.R389Q was reported to be associated with prelingual severe-to-profound deafness in a Turkish family [26] . However, in family PHLAI-01, p.R389Q co-segregated with moderate-to-profound hearing loss. A genetic modifier may explain the less severe hearing loss associated with p.R34X and p.R389Q variants in our families. For example, a trans-or cis-acting modifier that favors expression of short TMC1 isoforms with alternate start sites downstream of the p.R34X mutation may provide for partial function. The N-terminal region of TMC1 has been shown to interact with protocadherin-15 encoded by PCDH15 [10] . Interaction between protocadherin-15 and TMC1encoded by a short isoform that lacks a portion of the N-terminus may reduce mechanotransduction function and result in moderate-to-profound hearing loss.
TMC1 mutations are a relatively common cause of profound deafness in Pakistan with a frequency of 3.4 % in a cohort of 557 Pakistani families [1] . We found that the variants of TMC1 also make a contribution of approximately 7 % (95 % CI 1.6-12.7 %) to moderate or severe hearing loss. The milder phenotype seen in the affected individuals in these families could have an environmental component and may be due to a modifier in the genetic background of these individuals or both. In mouse, a quantitative trait locus (QTL) on chromosome 5 was reported to modify degeneration of the outer hair cells due to the dominant Beethoven (Bth) Tmc1 variant [38] . In humans, there may be similar modifiers of the auditory phenotype due to mutant alleles of TMC1. The question arises as to whether or not mutant Tmc1 mice engineered with the missense mutations reported here can partially rescue the complete loss of mechanotransduction present in a Tmc1 + Tmc2 double knock out mouse [39] . Positive results would suggest that these missense mutations are hypofunctional alleles, while genetic modifiers would remain a valid explanation for negative results.
Large families with interfamilial and intra-familial variability of hearing loss due to TMC1 variants may be helpful in identifying epistatic interactions that modify severity of hearing loss, including additional molecular partners that add to our understanding of the intricate mechanotransduction channel in vertebrate inner ears. In 1995, profound deafness segregating in an Indian family was mapped to the DFNB7/11 locus on chromosome 9 (q13-q21) [40] . Subsequently, mutations of TMC1 were shown to be the cause of severe-toprofound deafness in this family as well as numerous other families living in a variety of countries [1-3, 17, 18] . The contribution of TMC1 variants to less severe hearing loss in Pakistan now highlights a need to investigate its contribution globally to moderate or severe hearing loss.
